Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Targeting Vδ1+T-cells may help treat alopecia areata.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Aging slows wound healing due to weaker cells and immune response.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Stress-related hair loss was reversed with a special medication.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Blocking LFA-1 prevents hair loss in mice.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.